nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—Henoch-Schonlein purpura—Hydrochlorothiazide—nephrolithiasis	0.093	0.093	CcSEcCtD
Imiquimod—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.0401	0.0401	CcSEcCtD
Imiquimod—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.0269	0.0269	CcSEcCtD
Imiquimod—Stinging—Hydrochlorothiazide—nephrolithiasis	0.0261	0.0261	CcSEcCtD
Imiquimod—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.0234	0.0234	CcSEcCtD
Imiquimod—Gout—Hydrochlorothiazide—nephrolithiasis	0.0226	0.0226	CcSEcCtD
Imiquimod—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.0223	0.0223	CcSEcCtD
Imiquimod—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.022	0.022	CcSEcCtD
Imiquimod—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.0188	0.0188	CcSEcCtD
Imiquimod—Swelling—Hydrochlorothiazide—nephrolithiasis	0.0174	0.0174	CcSEcCtD
Imiquimod—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.0168	0.0168	CcSEcCtD
Imiquimod—Injury—Hydrochlorothiazide—nephrolithiasis	0.0167	0.0167	CcSEcCtD
Imiquimod—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.0162	0.0162	CcSEcCtD
Imiquimod—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0162	0.0162	CcSEcCtD
Imiquimod—Purpura—Hydrochlorothiazide—nephrolithiasis	0.0159	0.0159	CcSEcCtD
Imiquimod—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.0158	0.0158	CcSEcCtD
Imiquimod—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.0153	0.0153	CcSEcCtD
Imiquimod—Migraine—Hydrochlorothiazide—nephrolithiasis	0.0151	0.0151	CcSEcCtD
Imiquimod—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.0148	0.0148	CcSEcCtD
Imiquimod—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.0138	0.0138	CcSEcCtD
Imiquimod—Influenza—Hydrochlorothiazide—nephrolithiasis	0.0132	0.0132	CcSEcCtD
Imiquimod—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.0124	0.0124	CcSEcCtD
Imiquimod—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0123	CcSEcCtD
Imiquimod—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0122	CcSEcCtD
Imiquimod—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0121	CcSEcCtD
Imiquimod—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0117	CcSEcCtD
Imiquimod—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0116	CcSEcCtD
Imiquimod—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0116	CcSEcCtD
Imiquimod—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0116	CcSEcCtD
Imiquimod—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0115	CcSEcCtD
Imiquimod—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0115	CcSEcCtD
Imiquimod—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0111	CcSEcCtD
Imiquimod—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0106	CcSEcCtD
Imiquimod—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0105	CcSEcCtD
Imiquimod—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0102	CcSEcCtD
Imiquimod—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.01	0.01	CcSEcCtD
Imiquimod—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00988	0.00988	CcSEcCtD
Imiquimod—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00984	0.00984	CcSEcCtD
Imiquimod—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00947	0.00947	CcSEcCtD
Imiquimod—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00937	0.00937	CcSEcCtD
Imiquimod—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00923	0.00923	CcSEcCtD
Imiquimod—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00893	0.00893	CcSEcCtD
Imiquimod—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00856	0.00856	CcSEcCtD
Imiquimod—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00848	0.00848	CcSEcCtD
Imiquimod—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00843	0.00843	CcSEcCtD
Imiquimod—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00832	0.00832	CcSEcCtD
Imiquimod—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00827	0.00827	CcSEcCtD
Imiquimod—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00815	0.00815	CcSEcCtD
Imiquimod—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00811	0.00811	CcSEcCtD
Imiquimod—Cough—Hydrochlorothiazide—nephrolithiasis	0.00805	0.00805	CcSEcCtD
Imiquimod—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00786	0.00786	CcSEcCtD
Imiquimod—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00786	0.00786	CcSEcCtD
Imiquimod—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00786	0.00786	CcSEcCtD
Imiquimod—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00783	0.00783	CcSEcCtD
Imiquimod—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00776	0.00776	CcSEcCtD
Imiquimod—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00768	0.00768	CcSEcCtD
Imiquimod—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00753	0.00753	CcSEcCtD
Imiquimod—Shock—Hydrochlorothiazide—nephrolithiasis	0.00741	0.00741	CcSEcCtD
Imiquimod—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00735	0.00735	CcSEcCtD
Imiquimod—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00728	0.00728	CcSEcCtD
Imiquimod—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00718	0.00718	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00686	0.00686	CcSEcCtD
Imiquimod—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00681	0.00681	CcSEcCtD
Imiquimod—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00676	0.00676	CcSEcCtD
Imiquimod—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00671	0.00671	CcSEcCtD
Imiquimod—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00669	0.00669	CcSEcCtD
Imiquimod—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00663	0.00663	CcSEcCtD
Imiquimod—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00655	0.00655	CcSEcCtD
Imiquimod—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00649	0.00649	CcSEcCtD
Imiquimod—Pain—Hydrochlorothiazide—nephrolithiasis	0.00644	0.00644	CcSEcCtD
Imiquimod—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00621	0.00621	CcSEcCtD
Imiquimod—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00616	0.00616	CcSEcCtD
Imiquimod—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00598	0.00598	CcSEcCtD
Imiquimod—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00595	0.00595	CcSEcCtD
Imiquimod—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00595	0.00595	CcSEcCtD
Imiquimod—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00555	0.00555	CcSEcCtD
Imiquimod—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.0054	0.0054	CcSEcCtD
Imiquimod—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00533	0.00533	CcSEcCtD
Imiquimod—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00515	0.00515	CcSEcCtD
Imiquimod—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00498	0.00498	CcSEcCtD
Imiquimod—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00479	0.00479	CcSEcCtD
Imiquimod—Rash—Hydrochlorothiazide—nephrolithiasis	0.00475	0.00475	CcSEcCtD
Imiquimod—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00474	0.00474	CcSEcCtD
Imiquimod—Headache—Hydrochlorothiazide—nephrolithiasis	0.00472	0.00472	CcSEcCtD
Imiquimod—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00447	0.00447	CcSEcCtD
